10x Science Secures $4.8M Seed Funding for AI-Driven Protein Characterization
10x Science has raised $4.8 million in seed funding led by Initialized Capital, with participation from Y Combinator and other investors. The company aims to develop AI that automates molecular-level protein characterization, addressing a growing bottleneck in drug development. The platform is designed to deliver rapid, explainable insights, reducing the time required for complex analyses from months to minutes.
Topics: AI Biotechnology Drug Development Funding Protein Characterization